Abstract One new cleistanthane-type diterpene named engleromycenolic acid A (1), one new rosane-type diterpene named engleromycenolic acid B (2) and one new natural rosane-type diterpene, engleromycenol (3), along with three known rosanetype diterpenes, rosololactone (4), rosenonolactone (5) and 7-deoxyrosenonolactone (6) were isolated from cultures of the fungus Engleromyces goetzii, where it naturally grows on Alpine bamboo culms. The new compounds were elucidated based on their spectroscopic data. In addition, compounds 1-6 were evaluated for their cholesterol ester transfer protein (CETP) inhibition activity. This paper reports the isolation, structural elucidation, and CETP inhibition activity of these compounds.
Introduction
The fungus Engleromyces goetzii is widely distributed in Tibet, Sichuan and Yunnan province. It grows on Alpine bamboo culms, and ripens during rainy season from July to August. Local residents usually boil the fruiting bodies in water to treat infection, inflammation and cancer [1] [2] [3] . Previous investigation on the fruiting bodies of E. goetzii has led to the isolation of neoengleromycin, cytochalasin D and 19,20-epoxycytochalasin D [4] [5] [6] . There are no reports about the chemical constituents of the cultures of this fungus.
In order to search for more novel and potentially bioactive secondary metabolites, the chemical constituents of E. goetzii cultures were investigated by altering the culture conditions of the fungus and enlarging the fermentation scale. This investigation led to the isolation and identification of one new cleistanthane-type diterpene named engleromycenolic acid A (1), one new rosane-type diterpene named engleromycenolic acid B (2) and one new natural rosane-type diterpene named engleromycenol (3), along with three known rosane-type diterpenes: rosololactone (4), rosenonolactone (5) and 7-deoxyrosenonolactone (6) [7] . Their structures (Fig. 1) were elucidated based on the spectroscopic data analyses. The cholesterol ester transfer protein (CETP) inhibition activities of compounds 1-6 were examined and engleromycenolic acid A (1) showed CETP inhibition activity with IC 50 value at 7.55 lM.
There are two kinds of lipoproteinsin plasma: one is low-density lipoprotein (LDL) and another is high-density lipoprotein (HDL) [8, 9] . They are in charge of carrying cholesteryl esters in plasma. HDL is responsible for transferring cholesteryl esters from periphery plasma to the liver to metabolize, and LDL mediates the transport of cholesteryl esters from the liver to periphery plasma [8, 10, 11] . CETP promotes the transfer of cholesteryl esters from HDL to LDL. Inhibiting the activity of CETP can promotes the metabolism of cholesteryl esters in the liver and avoids accumulation of cholesterol esters in plasma that may cause atherosclerosis [9, [11] [12] [13] [14] . C NMR spectral data of 1 were similar to those of auricularic acid [15] , which indicated that 1 was a cleistanthane-type diterpene. However, there are certain differences as follows: the resonance of C-2 at d C 19.5 in auricularic acid is down shifted to d C 65.3 in 1, suggesting that the methylene at C-2 was replaced by an oxygen-bearing methine. Furthermore, the HMBC correlations from d H 2.41, 2.13, 1.00, 0.93 to carbon at d C 65.3, and the 1 H-1 H COSY correlations from d H 4.14 to d H 2.41, 2.13, 1.00 and 0.93 in 1, indicating that the oxygenbearing methane was placed at C-2. According to the molecular formula, we can conclude the oxygen-bearing methine at C-2 in 1 was substituted by a hydroxyl. In the ROSEY spectrum, the observed cross peaks of CH 3 In addition, the resonance of d C 21.7 (t) in 6 is down shifted to ), which implied five degrees of unsaturation. The 1D NMR spectroscopic data (Table 2) suggested that the backbone of 3 was the same as that of 2. Differences between them were identified to be the loss of a carbonyl and an oxygen-bearing methine, as well as the appearance of a hydroxymethyl and a methylene. The , indicated that the oxygen-bearing methine at C-2 in 2 was replaced by a methylene in 3. The configuration of C-8, C-9 and C-13 were established by comparing the NMR data of 3 with 2. The H-3 signal at d H 1.78 (1H, ddd, J = 13.5, 5.0, 3.5 Hz) suggested it to be equatorial b-oriented. In the ROSEY spectrum, the observed cross peak of d H 1.78 and 3.32 indicated the hydroxymethyl group in C-4 was located in axial b-oriented. In addition, there are no cross peak between H-18 (3.58, 3.32) and H-3a (1.27) in ROSEY spectrum, which further approved the conclusion above (Fig. 4) . According to this analysis, compound 3 was confirmed as engleromycenol.
Results and Discussion
Based on the spectroscopic analyses and the comparison with the literature, the known compounds were identified as rosololactone (4) [17, 18] , rosenonolactone (5) [18] and 7-deoxyrosenonolactone (6) [16] . Compound 3 has been reported in the conversion of 7-deoxyrosenonolactone to 3 by Connolly [19] . However, there are no reports about the NMR data of 3.
All the isolates were assayed for their CETP inhibition activity with the CETP Inhibitor Drug Screening Kit. The result showed that compounds 2-6 exhibited weak inhibition activity of CETP, however, engleromycenolic acid A (1) significantly inhibited the activity of CETP with the IC 50 value at 7.55 lM. Results of the study suggested that engleromycenolic acid A (1) might be a good candidate to develop effective therapeutic agent for the treatment of atherosclerotic cardiovascular diseases.
Experimental Section

General Experimental Procedures
The optical rotations were measured on a JASCO model 1020 polarimeter (JASCO International Co., Ltd., Tokyo, Japan). The IR spectra were obtained on a Bruker TENSOR 27FT-IR spectrometer (Bruker, Ettlingen, Germany) using KBr pellets. The 1D and 2D NMR data were performed on Bruker Avance III 600 and AM-400 instruments (Bruker, Rheinstetten, Germany) at room temperature. The chemical shifts (d) were expressed in ppm with reference to the solvent signals. The mass spectra (MS) were acquired on an API QSTAR time-offlight mass spectrometer (MDS Sciex, Ontario, Canada) or a VG Autospec-3000 spectrometer (VG, Manchester, England). Silica gel (200-300 mesh, Qingdao Marine Chemical Inc., Qingdao, China), Sephadex LH-20 (Amersham Biosciences, Sweden), and RP-18 gel (40-75 lm, Fuji Silysia Chemical Ltd., Japan) were used for column chromatography. Preparative HPLC (Prep-HPLC) was performed on an Agilent 1100 liquid chromatography system equipped with a ZOR-BAX SB-C 18 column (9.4 mm 9 150 mm). Precoated silica 
Fungal Material and Cultivation Conditions
Fruiting bodies of E. goetzii were collected from Shangri-La county in Yunnan Province, China. A voucher specimen has been deposited in the Herbarium of the Kunming Institute of Botany of the Chinese Academy of Sciences. The mycelia cultures were derived from the tissue plugs. The culture PDA medium consisted of glucose (5 %), peptone from porcine meat (0.15 %), yeast powder (0.5 %), KH 2 PO 4 (0.05 %) and MgSO 4 (0.05 %). The inoculums of E. goetzii were prepared in a 15 L-fermentation tank for 6 days under the following conditions: culture temperature, 24°C; initial pH, 6.0; agitation speed, 250 r/min; inoculation volume, 10 % (by volume); and aeration rate, 1.0 volume/culture volume/min. Subsequently, the liquid seed was transferred into a 100 L-fermentation tank for cultivation under the same conditions for 20 days to afford an 80 L culture broth.
Extraction and Isolation
The fermentation broth (80 L) was filtered, and the filtrate was concentrated to 10 L under reduced pressure and then extracted with ethyl acetate (3 9 10 L). The organic layer was evaporated to give a crude extract (350 g). Subsequently, the extract was subjected to silica gel column chromatography, using a petroleum ether/acetone gradient (100:0 ? 0:100 V/V) to afford fractions F 1 -F 7 based on TLC analysis. F 3 was purified using Sephadex LH-20 column chromatography (chloroform/methanol = 1:1 V/V) and then subjected to silica gel column chromatography (petroleum ether/acetone = 100:1 V/V) to afford compound 6 (50.0 mg). 
